GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (OSTO:ENZY) » Definitions » Cyclically Adjusted PB Ratio

Enzymatica AB (OSTO:ENZY) Cyclically Adjusted PB Ratio : 3.03 (As of Jun. 03, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Enzymatica AB Cyclically Adjusted PB Ratio?

As of today (2025-06-03), Enzymatica AB's current share price is kr3.06. Enzymatica AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr1.01. Enzymatica AB's Cyclically Adjusted PB Ratio for today is 3.03.

The historical rank and industry rank for Enzymatica AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSTO:ENZY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.39   Med: 3.17   Max: 18.07
Current: 2.96

During the past years, Enzymatica AB's highest Cyclically Adjusted PB Ratio was 18.07. The lowest was 1.39. And the median was 3.17.

OSTO:ENZY's Cyclically Adjusted PB Ratio is ranked worse than
66.23% of 693 companies
in the Drug Manufacturers industry
Industry Median: 1.94 vs OSTO:ENZY: 2.96

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Enzymatica AB's adjusted book value per share data for the three months ended in Mar. 2025 was kr0.651. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr1.01 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Enzymatica AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Enzymatica AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB Cyclically Adjusted PB Ratio Chart

Enzymatica AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.71 6.95 3.23 2.80 1.48

Enzymatica AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.31 1.99 1.69 1.48 4.37

Competitive Comparison of Enzymatica AB's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Enzymatica AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzymatica AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzymatica AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Enzymatica AB's Cyclically Adjusted PB Ratio falls into.


;
;

Enzymatica AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Enzymatica AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=3.06/1.01
=3.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzymatica AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Enzymatica AB's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.651/132.8245*132.8245
=0.651

Current CPI (Mar. 2025) = 132.8245.

Enzymatica AB Quarterly Data

Book Value per Share CPI Adj_Book
201506 1.411 99.995 1.874
201509 1.081 100.228 1.433
201512 0.719 100.276 0.952
201603 0.454 100.751 0.599
201606 1.598 101.019 2.101
201609 1.579 101.138 2.074
201612 1.403 102.022 1.827
201703 1.292 102.022 1.682
201706 1.187 102.752 1.534
201709 1.150 103.279 1.479
201712 1.092 103.793 1.397
201803 1.003 103.962 1.281
201806 0.850 104.875 1.077
201809 0.751 105.679 0.944
201812 1.033 105.912 1.295
201903 0.954 105.886 1.197
201906 0.851 106.742 1.059
201909 0.809 107.214 1.002
201912 0.771 107.766 0.950
202003 0.771 106.563 0.961
202006 0.708 107.498 0.875
202009 0.695 107.635 0.858
202012 0.690 108.296 0.846
202103 0.641 108.360 0.786
202106 0.858 108.928 1.046
202109 0.831 110.338 1.000
202112 0.774 112.486 0.914
202203 0.667 114.825 0.772
202206 0.577 118.384 0.647
202209 0.082 122.296 0.089
202212 0.711 126.365 0.747
202303 0.631 127.042 0.660
202306 0.570 129.407 0.585
202309 0.518 130.224 0.528
202312 0.431 131.912 0.434
202403 0.448 132.205 0.450
202406 0.375 132.716 0.375
202409 0.781 132.304 0.784
202412 0.727 132.987 0.726
202503 0.651 132.825 0.651

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Enzymatica AB  (OSTO:ENZY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Enzymatica AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Enzymatica AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzymatica AB Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB Headlines

From GuruFocus

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon 07-01-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson 12-07-2015

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi 12-20-2016